MJP Similarly have been buying regularly for 7 plus years and have never sold and dont intend to. Re the value at the end of the year the Immupel technology must surely be worth more than 2 cents on its own even if Parkinson application was not succesful. So I see far less down side risk.... but the potential upside ......pick your number.!!
Hope to hear that phase 3 6 patients given go ahead imminently by Medical board and agree NZ Trader it would be timely to get an update on the original 4 trial patients and of course to hear from Carol again would be terrific . However I also would understand why she may not want herself in public domain again.
Pretty exciting this next set of 6 patients with 4 of them receiving a triple dose and to both sides of the rain. Appreciate more may not always be better but the results will be intriuging.!
Final, Group 3, Phase II Trials, page-3
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.56M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $18.06K | 1.806M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 4223630 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 1051158 | 7 |
View Market Depth
| Last trade - 15.34pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.0¢ |
Change
0.000 ( 9.09 %) |
||||
| Open | High | Low | Volume | ||
| 1.0¢ | 1.0¢ | 1.0¢ | 144000 | ||
| Last updated 13.05pm 14/06/2024 ? | |||||
| 1AI (ASX) Chart |